Solid Renal Tumor Severity in von Hippel Lindau Disease is Related to Germline Deletion Length and Location

Human Mutation

Volumn 23, Issue 1, 2004, Pages 40-46

  Maranchie, Jodi K ^a   Afonso, Anoushka ^a   Albert, Paul S ^a   Kalyandrug, Sivaram ^c   Phillips, John L ^a   Zhou, Shubo ^a   Peterson, James ^a   Ghadimi, Bijan M ^a   Hurley, Katheen ^a   Riss, Joseph ^a   Vasselli, James R ^a   Ried, Thomas ^a   Zbar, Berton ^d   Choyke, Peter ^b   Walther, McClellan M ^a   Klausner, Richard D ^a   Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Cap Tech Info Serv (CTIS) Inc   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

C3orf10; Genotype; Germline deletion; HSPC300; Phenotype; Renal neoplasms; VHL

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ADULT; ANAMNESIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME 3P; DISEASE SEVERITY; FAMILIAL CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MAPPING; GENOTYPE; GERM LINE; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MORALITY; NUCLEOTIDE SEQUENCE; PANCREAS CYST; PHENOTYPE; PHEOCHROMOCYTOMA; PREVALENCE; PRIORITY JOURNAL; RADIOGRAPHY; SCORING SYSTEM; SOLID TUMOR; SOUTHERN BLOTTING; TELOMERE; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADULT; CARCINOMA, RENAL CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; GERM-LINE MUTATION; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; PHENOTYPE; SEQUENCE DELETION;

EID: 9144268968     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10302     Document Type: Article

References (19)

1. Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, Imreh S, Klein G, Zabarovsky ER. 2000. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene 19:1392-1399.
2. Breslow NE, Clayton DG. 1993. Approximate inference in generalized linear models. J Am Stat Assoc 88:9-25.
3. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li h, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M, Zbar B. 1995. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Murat 5:66-75.
4. Friedrich CA. 2001. Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 10:763-767.
5. Glasker S, Bender BU, Apel TW, van Velthoven V, Mulligan LM, Zentner J, Neumann HP. 2001. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 70:644-648.
6. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky IA, Duan R, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isacs WB, Lerman MI, Zbar B, Linehan WM. 1994. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85-90.
7. Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM. 1996. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 93:10589-10594.
8. Hes F, Zewald R, Peeters T, Sijmons R, Links T, Verheij J, Matthijs G, Leguis E, Mortier G, van der Torren K, Rosman M, Lips C, Pearson P, van der Luijt. 2000. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene. Hum Genet 106:425-431.
9. Knudson AG. 1995. VHL gene mutation and clear-cell renal carcinomas. Cancer J Sci Am 1:180.
10. Liang KY, Zeger SL. 1986. Longitudinal data analysis using generalized linear models. Biometrika 73:12-22.
11. Loh KC, Shlossberg AH, Abbott EC, Salisbury SR, Tan MH. 1997. Phaeochromocytoma: a ten-year survey. QJM 90:51-60.
12. Lott ST, Chandler DS, Curley SA, Foster CJ, El-Naggar A, Frazier M, Strong LC, Lovell M, Killary AM. 2002. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. Cancer Res 62:1952-1955.
13. Lubinski J, Hadaczek P, Podolski J, Toloczko A, Sikorski A, McCue P, Druck T, Huebner K. 1994. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res 54:3710-3713.
14. Moch H, Schraml P, Bubendorf L, Richter J, Gasser TC, Mihatsch MJ, Sauter G. 1998. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res 58:2304-2309.
15. Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther M, Linehan WM, Klausner RD, Ried T. 2001. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chromosomes Cancer 31:1-9.
16. Richards FM, Webster AR, McMahon R, Woodward ER, Rose S, Maher ER. 1998. Molecular genetic analysis of von Hippel-Lindau disease. J Intern Med 243:527-533.
17. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R, Linehan WM. 1998. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:417-423.
18. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. 1997. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406-410.
19. Yoshida M, Ashida S, Kondo K, Kobayashi K, Kanno H, Shinohara N, Shitara N, Kishida T, Kawakami S, Baba M, Yamamoto I, Hosaka M, Shuin T, Yao M. 2000. Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families. Jpn J Cancer Res 91:204-212.